Induction of Heme Oxygenase-1 Can Halt and Even Reverse Renal Tubule-Interstitial Fibrosis
Open Access
- 13 December 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (12), e14298
- https://doi.org/10.1371/journal.pone.0014298
Abstract
The tubule-interstitial fibrosis is the hallmark of progressive renal disease and is strongly associated with inflammation of this compartment. Heme-oxygenase-1 (HO-1) is a cytoprotective molecule that has been shown to be beneficial in various models of renal injury. However, the role of HO-1 in reversing an established renal scar has not yet been addressed. We explored the ability of HO-1 to halt and reverse the establishment of fibrosis in an experimental model of chronic renal disease. Sprague-Dawley male rats were subjected to unilateral ureteral obstruction (UUO) and divided into two groups: non-treated and Hemin-treated. To study the prevention of fibrosis, animals were pre-treated with Hemin at days -2 and -1 prior to UUO. To investigate whether HO-1 could reverse established fibrosis, Hemin therapy was given at days 6 and 7 post-surgery. After 7 and/or 14 days, animals were sacrificed and blood, urine and kidney tissue samples were collected for analyses. Renal function was determined by assessing the serum creatinine, inulin clearance, proteinuria/creatininuria ratio and extent of albuminuria. Arterial blood pressure was measured and fibrosis was quantified by Picrosirius staining. Gene and protein expression of pro-inflammatory and pro-fibrotic molecules, as well as HO-1 were performed. Pre-treatment with Hemin upregulated HO-1 expression and significantly reduced proteinuria, albuminuria, inflammation and pro-fibrotic protein and gene expressions in animals subjected to UUO. Interestingly, the delayed treatment with Hemin was also able to reduce renal dysfunction and to decrease the expression of pro-inflammatory molecules, all in association with significantly reduced levels of fibrosis-related molecules and collagen deposition. Finally, TGF-β protein production was significantly lower in Hemin-treated animals. Treatment with Hemin was able both to prevent the progression of fibrosis and to reverse an established renal scar. Modulation of inflammation appears to be the major mechanism behind HO-1 cytoprotection.Keywords
This publication has 59 references indexed in Scilit:
- The NRF2–heme oxygenase-1 system modulates cyclosporin A-induced epithelial–mesenchymal transition and renal fibrosisFree Radical Biology & Medicine, 2010
- Dystroglycan in the Diagnosis of FSGSClinical Journal of the American Society of Nephrology, 2009
- Heme oxygenase: the key to renal function regulationAmerican Journal of Physiology-Renal Physiology, 2009
- Heme Oxygenase-1 Inducer Hemin Attenuates the Progression of Remnant Kidney ModelNephron Experimental Nephrology, 2009
- BMP6 reverses TGF-β1-induced changes in HK-2 cells: implications for the treatment of renal fibrosisActa Pharmacologica Sinica, 2009
- Heme Oxygenase-1 Deficiency Promotes Epithelial-Mesenchymal Transition and Renal FibrosisJournal of the American Society of Nephrology, 2008
- Multifunctionality of PAI-1 in fibrogenesis: Evidence from obstructive nephropathy in PAI-1–overexpressing miceKidney International, 2005
- Heme Oxygenase and the KidneyDNA and Cell Biology, 2002
- Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized ratsKidney International, 1996
- Differential regulation of cardiac heme oxygenase‐1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxiaFEBS Letters, 1996